Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INFANT BACTERIAL THERAPEUTICS AB (PUBL)

(IBT B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Infant Bacterial Therapeutics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021

08/13/2021 | 02:00am EDT

Infant Bacterial Therapeutics AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was SEK 29.164 million compared to SEK 27.915 million a year ago. Net loss was SEK 29.165 million compared to SEK 27.937 million a year ago. For the half year, operating loss was SEK 28.712 million compared to SEK 26.708 million a year ago. Net loss was SEK 28.714 million compared to SEK 26.759 million a year ago.


© S&P Capital IQ 2021
All news about INFANT BACTERIAL THERAPEUTICS AB (PUBL)
09/30INFANT BACTERIAL THERAPEUTICS : Next recruitment milestone reached in IBT's Phase III Stud..
AQ
09/30Infant Bacterial Therapeutics Announces Next Recruitment Milestone Reached in Ibt’S Pha..
CI
09/23INFANT BACTERIAL THERAPEUTICS : IBT - After safety review The Connection study is now agai..
AQ
09/22INFANT BACTERIAL THERAPEUTICS : After safety review The Connection study is now again open..
AQ
09/22Infant Bacterial Therapeutics AB Announces After Safety Review the Connection Study Is ..
CI
09/13INFANT BACTERIAL THERAPEUTICS : announces that a new patent is granted in Mexico
AQ
09/10INFANT BACTERIAL THERAPEUTICS : today announces that a new patent is granted in Mexico
AQ
09/10Infant Bacterial Therapeutics Announces the Mexican Patent Office Grants New Patent
CI
08/25INFANT BACTERIAL THERAPEUTICS : Recruitment of the smallest infants in the Connection stud..
AQ
08/25Infant Bacterial Therapeutics AB Announces Recruitment of the Smallest Infants in the C..
CI
More news
Financials
Sales 2020 - - -
Net income 2020 -72,0 M -8,40 M -8,40 M
Net cash 2020 423 M 49,4 M 49,4 M
P/E ratio 2020 -17,5x
Yield 2020 -
Capitalization 908 M 106 M 106 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float 89,2%
Chart INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Duration : Period :
Infant Bacterial Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Staffan Strömberg Chief Executive Officer
Marie-Louise Alamaa Chief Financial Officer
Peter Michael Rothschild Chairman
Eamonn Connolly Chief Scientific Officer
Jonas Rastad Chief Medical Officer